NCT04592744View on ClinicalTrials.gov

Angiotensin 2 for AKI After OLT

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 8, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
Cirrhosis, LiverEnd Stage Liver DIseaseAcute Kidney InjuryLiver Transplant; Complications
Interventions
DRUG

Angiotensin II

Angiotensin II infusion for Intraoperative management during liver transplantation

DRUG

Norepinephrine

Vasopressor infusion for management of Intraoperative hypotension in liver transplantation.

Trial Locations (1)

90095

Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER